What is your diagnosis?
News
All series
All News
Advertisement
The Cole Eye Institute will present a Retina Summit CME symposium immediately before the ARVO 2013 annual meeting.
Optos plc has received 510(k) clearance from the FDA for microperimetry as part of the OptosOCT SLO.
Gene therapy is making headway in inherited retinal diseases that were previously thought to be untreatable.
Advertisement
Advertisement
Trending on Modern Retina
1
Frank Holz, MD, FEBO, FARVO, highlights new treatment developments at EURETINA
2
Q&A: The ARCHER trial and the importance of continued GA research
3
Q&A: What is the value of the YOURS program at EURETINA?
4
